Celldex Therapeutics
CLDX
#4679
Rank
A$2.86 B
Marketcap
A$43.00
Share price
-2.71%
Change (1 day)
47.88%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2025 (TTM): -A$0.44 Billion

According to Celldex Therapeutics's latest financial reports the company's current earnings are A$1.54 Million. a decrease over its 2024 earnings that were of -A$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1986 to 2025

Annual earnings

Year Earnings Change
2025 -A$0.42 Billion47.31%
2024 -A$0.29 Billion37.34%
2023 -A$0.21 Billion32.63%
2022 -A$0.16 Billion54.88%
2021 -A$0.11 Billion39.49%
2020 -A$72.32 Million-9.08%
2019 -A$79.54 Million-28.64%
2018 -A$0.12 Billion-30.11%
2017 -A$0.16 Billion-17.75%
2016 -A$0.2 Billion4.5%
2015 -A$0.19 Billion4.09%
2014 -A$0.18 Billion51.57%
2013 -A$0.12 Billion40.1%
2012 -A$83.95 Million
2010 -A$1.82 Million-96.59%
2009 -A$53.39 Million
2006 -A$32.63 Million
2004 -A$19.82 Million15.75%
2003 -A$17.12 Million-18.69%
2002 -A$21.06 Million-41.22%
2001 -A$35.82 Million59%
2000 -A$22.53 Million27.65%
1999 -A$17.65 Million53.12%
1998 -A$11.53 Million2.6%
1997 -A$11.24 Million-33.62%
1996 -A$16.93 Million-1.69%
1995 -A$17.22 Million22.92%
1994 -A$14.01 Million-0%
1993 -A$14.01 Million
1991 -A$8.61 Million90.32%
1990 -A$4.53 Million10.71%
1989 -A$4.09 Million833.33%
1988 -A$0.44 Million-400%
1987 A$0.14 M-125%
1986 -A$0.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.86 B-3,646.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$13.09 B-3,223.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.43 B-3,543.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-A$4.1 Million-99.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-A$1.16 Billion 175.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$30.14 M-107.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.24 B-157.52%๐Ÿ‡บ๐Ÿ‡ธ USA